Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Episodes

Podcast: How can you speak the same language as your healthcare professional?

Physiotherapist Josefa Domingos opens up with her patient Idelta Oliveira

READ MORE

Global update

Coronavirus and Parkinson’s: what you need to know

How the Covid-19 pandemic is affecting people with Parkinson’s

READ MORE

Advances

Apple says new CareKit platform will ‘empower’ Parkinson’s patients

Open-source platform to transform the way we think about health

READ MORE